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Abstract
Discovery of biomarkers is a fast developing field in proteomics research. Liquid chromatography coupled on line to mass spectrometry
(LC–MS) has become a powerful method for the sensitive detection, quantification and identification of proteins and peptides in biological fluids
























dnd identification in proteomics studies. To perform future comparative analyses of samples from a serum bank of cervical cancer patients in
longitudinal and cross-sectional manner, methodology based on the depletion of high-abundance proteins followed by tryptic digestion and
C–MS has been developed. Two sample preparation methods were tested in terms of their efficiency to deplete high-abundance serum proteins
nd how they affect the repeatability of the LC–MS data sets. The first method comprised depletion of human serum albumin (HSA) on a dye ligand
hromatographic and immunoglobulin G (IgG) on an immobilized Protein A support followed by tryptic digestion, fractionation by cation-exchange
hromatography, trapping on a C18 column and reversed-phase LC–MS. The second method included depletion of the six most abundant serum
roteins based on multiple immunoaffinity chromatography followed by tryptic digestion, trapping on a C18 column and reversed-phase LC–MS.
epeatability of the overall procedures was evaluated in terms of retention time and peak area for a selected number of endogenous peptides
howing that the second method, besides being less time consuming, gave more repeatable results (retention time: <0.1% RSD; peak area: <30%
SD). Application of an LC–MS component detection algorithm followed by principal component analysis (PCA) enabled discrimination of serum
amples that were spiked with horse heart cytochrome C from non-spiked serum and the detection of a concentration trend, which correlated to
he amount of spiked horse heart cytochrome C to a level of 5 pmol cytochrome C in 2l original serum.
2006 Elsevier B.V. All rights reserved.
eywords: Proteomics; Mass spectrometry; Biomarker; HPLC; Cervical cancer
. Introduction
Various methods have been applied in recent years for the
iscovery of biomarkers or biomarker patterns of major human
iseases, especially for various types of cancer [1–13]. Amongst
hese surface enhanced laser desorption ionization mass spec-
rometry (SELDI-MS), which combines on-chip sample prepa-
ation with mass spectrometric analysis, has taken a prominent
∗ Corresponding author. Tel.: +31 50 363 3338; fax: +31 50 363 7582.
E-mail address: r.p.h.bischoff@rug.nl (R. Bischoff).
1 Present address: Division of Analytical Biosciences, University of Leiden,
.O. Box 9502, 2300 RA Leiden, The Netherlands.
2 Present address: Bioinformatics Laboratory, Academic Medical Center
msterdam, University of Amsterdam, 1100 DE Amsterdam, The Netherlands.
position [14], although more recent results question the viability
of this approach [15,16]. Liquid chromatography coupled on line
to mass spectrometry (LC–MS) is one of the most widely used
analytical methods with applications going beyond proteomics
and biomarker discovery. It has the advantage of combining pow-
erful separation by one- or multi-dimensional chromatography
with the exquisite selectivity and sensitivity of modern mass
spectrometers. The complexity of a typical LC–MS data set
reaches 108 data points per sample at a resolution of 0.1 amu
in the m/z domain and a chromatographic run time of approx-
imately 2 h (7000 data points). It is thus pivotal to apply data
pre-processing algorithms to reduce data complexity and multi-
variate statistics to reduce dimensionality to be able to compare
data sets obtained from longitudinal or cross-sectional patient
studies comprising significantly less samples than the number
of original variables in the data.
021-9673/$ – see front matter © 2006 Elsevier B.V. All rights reserved.
oi:10.1016/j.chroma.2006.02.088
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Sample preparation is an often underestimated problem in
comparative biomarker analysis. Notably in serum there are
a few highly abundant proteins that will prevent detection of
many minor proteins present in the sample. Since it is unlikely
that high abundance proteins like albumin or transferrin will be
biomarkers for specific diseases, it is necessary for biomarker
discovery methodology to detect and quantify proteins present
at lower concentrations. One way to reduce serum complexity
is chromatographic removal of the most abundant proteins. In
human serum, the most abundant proteins are albumin and -
globulins. Earlier [17] we tested different depletion strategies to
reduce the level of abundant proteins based on either specific
antibodies, dye ligands (for albumin) [18] or Protein A and G
(for -globulins) [19,20]. Other approaches based, for example,
on ultrafiltration showed lower selectivity for these target pro-
teins but allowed on the other hand to concentrate the sample
[21]. Co-depletion of proteins and peptides is a concern when
employing such depletion strategies [22].
LC–MS is particularly adapted to the separation and detec-
tion of peptides. This has triggered development of the so-called
“shotgun” proteomics approach [23]. Contrary to proteomics
based on two-dimensional polyacrylamide gel electrophoresis
(2D-PAGE), where the proteins are separated prior to tryp-
tic digestion, trypsin digestion precedes the separation step.
The shotgun approach results therefore in extremely complex































represented in the first principal component after non-supervised
data pre-processing and PCA down to a lower level of 50 pmol
cytochrome C in 20l serum.
2. Experimental
Serum samples were obtained from the Department of Gyne-
cological Oncology (University Medical Center Groningen, The
Netherlands) and stored at −80 ◦C in aliquots. All intermediate
fractions were stored at −20 ◦C. To develop and optimize the
analytical procedure, serum from a single cervical cancer patient
with a squamous cell carcinoma antigen-1 (SCCA-1) [26] level
of 2.2 ng/ml (determined by ELISA) was used.
2.1. Sample preparation of human serum
2.1.1. Method 1
Two hundred and forty microliters of diluted crude serum
(60l of crude serum mixed with 180l of 20 mM NaH2PO4
pH 7.0) wer depleted on a 1 ml Bio-Rad Aurum Serum Pro-
tein (www.biorad.com) column according to the manufacturer’s
instructions. Protein concentrations were determined with the
Micro BCATM Protein assay reagent kit (www.piercenet.com)
and calculated for an average protein molecular weight of
50 kDa. BSA was used as the calibration standard.































iion methodology. Very high efficiency separation systems have
ecently been applied to this problem allowing to identify a wide
ange of proteins in plasma or serum [13]. A new approach
eveloped recently combines the use of immunoaffinity deple-
ion with reversed-phase separation of whole proteins at elevated
emperatures to reduce sample complexity prior to identification
f proteins in human serum [24]. This approach allowed, for
xample, to identify hepatocyte growth factor, which is present
t a level of 20 ng/ml.
In this study, we combined efficient depletion of high abun-
ance proteins with LC–MS based shotgun proteomics followed
y data pre-processing to select information-rich chromato-
raphic traces based on the CODA algorithm [25]. This was
ollowed by multivariate statistical analysis of the selected traces
y principal component analysis (PCA) to evaluate the per-
ormance of the method to discriminate samples. Initially we
ested two approaches for the preparation of human serum for
C–MS analysis. Removal of abundant proteins was performed
y dye ligand or antibody-based multiple-affinity chromatogra-
hy, which eliminates the six most abundant serum proteins. In
he case of dye ligand chromatography, a two-dimensional chro-
atographic system was employed consisting of strong cation
xchange followed by reversed-phase HPLC. Proteins remain-
ng after the multiple-affinity removal step were directly digested
nd analyzed by reversed-phase LC–MS. The performance of
ach approach was assessed in terms of repeatability of reten-
ion times and peak areas for a selected number of endogenous
eptides showing that the repeatability of the second method was
uperior. The discriminatory power of this method was assessed
y adding decreasing amounts of horse heart cytochrome C to the
riginal serum proving that a concentration trend was correctlyere digested with trypsin (1:20, w/w enzyme to sub-
trate) at 37 ◦C overnight (sequencing grade modified trypsin
rom Promega, Cat# V5111, USA). One hundred micro-
rams of digested, depleted serum were fractionated by strong
ation exchange HPLC (Poly SEA 2.0 mm × 150 mm, 5m,
00 A˚ column, Michrom BioResources, Auburn, CA, USA)
perated at 0.3 ml/min on a Beckman Gold HPLC system
www.beckman.com). The salt gradient ranged from 0 to 1 M
Cl with a slope of 10 mM/min. The mobile phase com-
rised two buffers: A: 5 mM KH2PO4/H3PO4 pH 3, 25%
cetonitrile and B: 5 mM KH2PO4/H3PO4 pH 3, 25% ace-
onitrile, 1 M KCl. The following fractions were collected: #1
0–50 mM) KCl, 17–21 min, #2 (50–100 mM) KCl, 22–26 min,
3 (100–150 mM) KCl, 27–31 min and #4 (150–200 mM) KCl,
2–36 min. Samples were concentrated by vacuum centrifuga-
ion (Speed Vac, Univapo 150H, UniEquip, Martinsried, Ger-
any) to approximately 1 ml to remove acetonitrile and fractions
3 and #4 were pooled together because of their low concentra-
ion of peptides. The concentrated fractions were passed through
Macro Trap 200 hydrophilic C18 silica cartridge (ODS-AQ;
mm × 8 mm; Michrom, USA) for desalting and further con-
entration by loading at 0.3 ml/min followed by a column wash
ith 2 ml of 5% acetonitrile, 0.1% formic acid in H2O. Peptides
ere eluted with 0.5 ml 70% acetonitrile, 0.1% formic acid at a
ow rate of 1 ml/min. Acetonitrile was evaporated by vacuum
entrifugation (Speed Vac) and the final volume was adjusted
o 150l. Pure acetonitrile and pure formic acid were added to
each final concentrations of 5% acetonitrile and 0.1% formic
cid, respectively. All LC–MS analyses were performed on an
gilent 1100 capillary HPLC system coupled on-line to an SL
on trap (www.home.agilent.com) equipped with an AtlantisTM
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dC 18 (1.0 mm × 150 mm, 3m) column (www.waters.com).
Forty microliters of the pretreated fractions corresponding to
∼8g or 160 pmol of total protein digest (calculation based on
a 50 kDa protein) were injected. Peptides were eluted in a lin-
ear gradient from 0 to 70% (0.5%/min) acetonitrile with 0.1%
formic acid at a flow-rate of 20l/min.
2.1.2. Method 2
Eighty microliters (80% of the total amount of diluted crude
serum (20l of crude serum mixed with 80l of buffer A
(Agilent)) were depleted on a Multiple Affinity Removal col-
umn (Agilent, 4.6 mm × 50 mm, Part # 5185–5984) according
to the manufacturer’s instructions.The flow-through fraction
(depleted serum collected between 2 and 6 min) of a total vol-
ume of approximately 1 ml was collected. Protein concentra-
tions were determined as in Method 1. One hundred microliters
(∼10% of the total amount, which corresponded to ∼7g or
140 pmol of total protein considering a molecular weight of
50 kDa) of depleted serum were digested with trypsin (1:20, w/w
enzyme to substrate) under the same conditions as described in
Method 1. All LC–MS analyses were performed on the iden-
tical LC–MS system (Agilent 1100 capillary HPLC; SL ion
trap mass spectrometer) except that an in-line trap column was
used (AtlantisTM dC 18, 3m, 2.1 mm × 20 mm Guard col-
umn (www.waters.com)). One hundred microliters depleted and























Method 2 crude sample of the same patient was also spiked
with horse heart cytochrome C (Sigma, www.sigmaaldrich.com)
before depletion (210 pmol cytochrome C per 20l of original
serum) and the procedure repeated four times.
2.5. Standard addition of cytochrome C
Horse heart cytochrome C was added to 20l of the original
serum over a range of 25 pmol–1.26 nmol, of which 10% were
subjected to the final LC–MS analysis to evaluate the discrim-
inatory capacity of Method 2. Cytochrome C was alternatively
digested with trypsin and added in the same amounts to depleted
and trypsinized serum (2l equivalent) prior to LC–MS to eval-




The original Bruker Daltonics LC–MS data files were con-
verted into ASCII-format with the Bruker Data Analysis soft-
ware. The original m/z ratios (0.1 amu resolution) were com-
bined into 1 amu bins by rounding the m/z ratios off to the closest
integer values. This reduced the amount of data by almost a
factor 10 but, more importantly, avoided misclassification of





























tode for 40 min (0.1% aq. formic acid and 3% acetonitrile
t a flow-rate of 50l/min) and eluted on-line to the analyt-
cal column (AtlantisTM dC 18, 1.0 mm × 150 mm, 3m col-
mn (www.waters.com)). Gradient conditions were identical to
ethod 1.
.2. Polyacrylamide gel electrophoresis (SDS–PAGE)
SDS–PAGE was performed in a Mini-Protein III cell (Bio-
ad, www.biorad.com) using 12% gels with 0.1% SDS accord-
ng to the manufacturer’s instructions. Staining was per-
ormed with Coomassie Brilliant Blue R concentrate (Sigma,
ww.sigmaaldrich.com) diluted and used as prescribed by the
anufacturer.
.3. Mass spectrometry
The following conditions were used for mass spectrometry
uring LC–MS. Nebulizer gas: 16.0 psi N2, drying gas: 6.0 l/min
2, skimmer: 40.0 V, cap. exit: 158.5 V, Oct. 1: 12.0 V, Oct. 2:
.48 V, Oct. RF: 150 Vpp (Voltage, Peak Power Point), Lens
: −5.0 V, Lens 2: −60.0 V, Trap drive: 53.3, T◦: 325◦, Scan
esolution: Enhanced, 5500 m/z per second scan speed. Target
ass: 600. Scan range: 100–1500 m/z. Spectra were saved in
entroid mode. LC–MS chromatographic data were analyzed
ith Bruker Data Analysis software, version 2.1 (Build 37).
.4. Repeatability study
A serum sample from a cervical cancer patient was treated
ix-times with Method 1 and five-times with Method 2. Inass spectra introduced a slight error that could lead to mis-
lignment of m/z traces. In order to classify the individual m/z
races with respect to their “information content”, the component
etection algorithm (CODA) developed by Windig et al. was
pplied [25]. This algorithm compares the raw chromatograms
ith their smoothed (using a moving average) and standard-
zed versions. The difference between the raw and smoothed
hromatogram is small for high quality chromatograms (and the
CODA quality score” with a value ranging between 0 and 1, is
igh), while the opposite is true for chromatograms containing
ainly background noise and/or spikes. By setting a threshold
he user can define down to which level of quality m/z traces
ill be considered for the subsequent statistical analysis. In our
tudy mass traces with a quality value higher than 0.98 were
etained for further analysis meaning that only about 45 very
igh quality chromatograms were considered. The total ion cur-
ent (TIC) was calculated from all mass traces or from the CODA
elected high quality ones. The latter represented rather well
he main characteristics of the original TIC, while background
oise was essentially eliminated. Information of the peaks
resent in this rather conservative class of mass traces turned
ut to be sufficient for the detection of interpretable patterns
n the data, for example separation of spiked from non-spiked
amples.
.6.2. Multivariate statistical analysis
To perform multivariate statistical data analysis of multi-
le LC–MS samples, information present in the union set of
ll selected high-quality mass traces was used. For each high-
uality mass trace in the union set of mass traces, the peak with
he highest intensity was obtained and entered in a peak list.
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This peak list was further analyzed using principal component
analysis. PCA is a widely used statistical technique that enables
search for and visualization of patterns present in highly multi-
variate datasets [27]. In this study mainly biplots were used to
analyse the available LC–MS peak lists. All statistical data anal-
ysis calculations were performed in the MATLAB programming
environment (version 3.5.1, release 13).
2.7. Protein identiﬁcation
1D nanoLC–ESI–MS–MS analysis was performed on an
integrated nanoLC system (Agilent) comprising a binary gradi-
ent pump with a cooled autosampler, an auxilary pump for load-
ing and washing the trap column, a column switching module
configured for trap plus analytical capillary column, and a Q-Star
XL API mass spectrometer (Applied Biosystems, MDS Sciex,
Framingham, USA) fitted with nano-LC sprayer and operated
under Analyst QS 1.1 control. Injected samples were first trapped
and desalted isocratically on an LC-Packings PepMap C18-
Precolumn Cartridge (5m, 300m I.D. × 1 mm; Dionex, Sun-
nyvale, CA, USA) for 5 min with 0.1% formic acid delivered by
the auxillary pump at 10l/min after which the peptides were
eluted from the trap column and separated on an analytical C18
capillary column (5 cm × 75m, Atlantis) connected in-line to
the mass spectrometer, at 250 nl/min using a 90 min gradient of



























Fig. 1. Schematic description of two methods for sample preparation and analy-
sis of human serum. The main differences between the methods are that Method
1 uses dye ligand affinity chromatography and Protein A for depletion of albu-
min and IgG (Aurum column, BioRad) while Method 2 employs a multiple
affinity removal column (Agilent) based on a mixture of antibodies and Protein
A. Method 1 includes a strong cation-exchange prefractionation step, while this
step was omitted in Method 2.
method was repeated six-times in order to evaluate the overall
repeatability. To this end 10 endogenous peptides from three
cation-exchange fractions that covered the entire retention time
range of eluting peptides in serum were selected and their respec-
tive extracted ion chromatograms integrated. While repeatability
in terms of retention times was satisfactory (RSD < 0.8%) peak
areas differed over a wide range (RSD between 12 and 160%)
(see Table 1). We argued that the low repeatability with respect
to peak area of some peptides was due to the cation-exchange
prefractionation step, since fraction collection from a highly
complex chromatogram of partially resolved peaks can easily
lead to arbitrary cutting of component peaks and thus to major
quantitative differences. This effect can be depicted in Fig. 2A
showing six repetitions of the final LC–MS analysis using
Method 1 clearly indicating two groups of three chromatograms.
In order to overcome this limitation, we improved the efficiency
of the depletion step by employing a multiple-affinity removal
column (removes albumin, IgG, IgA, transferrin, haptoglobin,
and 1-antitrypsin) and eliminating the cation-exchange chro-
matography step (Fig. 1, Method 2). Visual inspection of
the chromatograms showed already that this approach was
superior in terms of repeatability (Fig. 2B). An overview of
the efficiency of depletion by both methods was obtained
by SDS–PAGE showing that Method 2 (multiple depletion)







cThe QStar XL mass spectrometer was operated in
nformation-dependent acquisition (IDA) mode. In MS mode,
ons were screened from m/z 300 to 1500, and MS–MS spec-
ra were acquired from m/z 50 to 2000 (pulsing mode on). In
tandard acquisition mode, each acquisition cycle was com-
rised of a 1s MS and a 1s MS–MS scan. In IDA mode the
our most intense peaks were selected and MS–MS spectra
cquired when their intensities exceeded 30 counts, In product
on mode, MS–MS spectra were acquired for selected precursor
ons (m/z 619.2, 694.4, 753.5, 682.5 and 909.6) without thresh-
ld restriction. Acquired MS–MS spectra were searched against
he SwissProt/Trembl database with a mass tolerance of 1.1 Da
or the precursor and 0.15 Da for the obtained fragment ions.
hit was considered significant when the score exceeded 2.0,
hich corresponds to a confidence interval of more than 99%.
. Results
.1. Preparation of human serum for LC–MS analysis
Depletion of high-abundance proteins is one way to enhance
he capability of proteomic methods to detect subtle changes
n the protein profile of human serum. Previously we reported
n the efficacy of several depletion columns to remove albumin
nd -globulins [17]. Method 1 (Fig. 1), used here as a first
pproach, is partially based on a previously published protocol,
hich was extended and optimized in the current work. Method 1
elies on dye-ligand affinity chromatography to remove albumin
nd Protein A to remove IgG. The subsequent steps comprise
rypsin digestion and strong cation exchange chromatography
SCX) to fractionate the sample prior to LC–MS analysis. ThisThis is in agreement with recently published data using 2D
el electrophoresis [28]. While Method 1 removed approxi-
ately 70% of total serum protein, Method 2 removed 90–95%
ccording to determination of the total protein content after
epletion. This allowed an increased loading capacity of the
emaining digested proteins of 10–20-fold on the reversed-phase
olumn.
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Table 1
Repeatability of Method 1 (six repetitions) and Method 2 (five repetitions) (see
Fig. 2) in terms of retention time and peak area for a selected number of endoge-
nous peptides
m/z Average RT (min) %RT dev. Average area % Area dev.
Method 1. CEX fraction 1
772.1 100.72 0.25 4.9 × 106 36.8
472.2 106.20 0.23 3.0 × 107 85.5
552.9 108.95 0.79 9.7 × 105 104.8
713.8 111.62 0.24 5.4 × 107 50.0
682.5 115.25 0.26 7.3 × 106 157.5
Method 1. CEX fraction 2
619.2 99.75 0.05 2.1 × 107 24.0
694.4 103.95 0.08 4.1 × 107 11.9
753.5 111.62 0.10 9.9 × 107 113.2
909.6 114.37 0.12 2.5 × 106 94.1
Method 1. CEX fraction 3
525.1 99.34 0.50 2.2 × 107 73.8
Method 2.
756.7 109.40 0.06 4.5 × 107 13.1
753.5 110.78 0.04 3.3 × 107 13.7
909.6 113.54 0.08 3.8 × 106 27.5
682.5 114.20 0 8.3 × 107 14.1
619.2 99.90 0.05 4.4 × 107 20.1
694.4 104.20 0.04 2.4 × 107 9.1
Neither retention times nor peak areas were normalized. In bold: Peaks detected
in both methods (m/z 619.2 and 694.4: doubly charged ions of peptides
[DLATVYVDVDVLK and VSFLSALEEYTK, respectively] from apolipopro-
tein A (accession number (P02647, SwissProt/Trembl);m/z 682.5: triply charged
ion of [LLLQQVSLPELPGEYSMK] and m/z 753.5: doubly charged ion of
[AAQVTIQSSGTFSSK] from alpha-2-macroglobulin precursor (P01023); m/z
909.6: doubly charged ion of [SNLDEDIIAEENIVSR] from human comple-
ment C3 precursor (P01024).
3.2. Repeatability
As indicated in Fig. 2, Method 2 resulted in a better repeatabil-
ity in terms of retention times (Method 1: <0.8% RSD; Method
2: <0.1% RSD). This may be due to the use of an in-line trap
column for sample clean-up and focusing. It is noteworthy that
retention time differences of five repetitive LC–MS runs ranged
from 0 to 6 s in the case of Method 2 without any alignment
of the chromatograms. Importantly, Method 2 proved also to be
significantly more repeatable with respect to the observed peak
areas for identical, selected endogenous peptide peaks (Method
1: 12–160% RSD; Method 2: 10–30% RSD). This was partic-
ularly for those peptides that showed large standard deviations
with Method 1 (Table 1). This may be attributed to the sig-
nificantly reduced number of sample preparation steps and in
particular elimination of the fraction collection step by strong
cation-exchange HPLC.
To estimate the repeatability of the developed methods on a
more global scale, CODA was applied to all measured replicates.
So instead of limiting ourselves to 6–10 univariate repeatability
measures, all CODA-selected mass traces were used to compare
the methods. Fig. 4 displays the calculated CODA quality scores
for the different mass traces of the replicates prepared accord-
ing to sample preparation Method 1 (top) or Method 2 (bottom).
Since the image plots of the first, second and third SCX fraction
gave similar results, only the quality values of the second frac-
tion are visualized. While for Method 2 the quality values of the
different replicates are higher and very similar over the whole
m/z range, Method 1 shows far less repeatable quality values.
Replicates 2, 3 and 6 (Method 1) differ significantly from repli-
cates 1, 4 and 5 (see also Fig. 2). This result is confirmed after
application of PCA to the peak lists generated from the high
quality mass traces (CODA score > 0.98) selected by CODA. In
the scores plot (not shown here) the replicates separate into two
groups: a group containing replicates 2, 3 and 6 and a group with
replicates 1, 4 and 5. Such analytical variability may interfere
with detecting patterns of samples when analyzing patient sera
or indicate false clusters.
3.3. Data analysis
In view of trying to discover differences in the abundance
of peptides amongst samples from cancer patients at various
stages of disease, it is pivotal that baseline variations are kept
to a minimum due to methodological variability. Thus, Method
2 was chosen for further work. In an effort to evaluate the dis-
criminatory capacity of the analytical and data analysis method-
ology, 210 pmol of horse heart cytochrome C were added to
20l of the original serum sample and analyzed with Method
2 as described above. LC–MS data was acquired for in total






























spiked replicates. Peak lists for all 9 LC–MS data files were
btained after application of the binning algorithm and usage of
ODA. Fig. 5 summarizes the results of PCA of the union peak
ist. The biplot shows besides the scores of the nine samples
4 spiked samples = red diamonds, five normal samples = blue
quares) also the loadings of the high quality mass traces (45
ass traces = green triangles) that were used for the statistical
nalysis. In Fig. 5A the spiked samples are clearly separated
rom the normal (non-spiked) samples. Especially m/z traces
83, 748 and 965 contribute significantly to the discrimination
f the spiked from the normal samples (Fig. 5B). All of these m/z
alues are related to tryptic peptides of cytochrome C (the m/z
alues of 483 and 965 correspond to doubly and singly charged
ons of the same peptide).
Since depletion of high abundance proteins, notably albu-
in has been reported to lead to co-depletion of other proteins,
eptides and metabolites that are bound to albumin [21,22],
e investigated the recovery of the added cytochrome C from
0l serum of a cervical cancer patient (same patient serum as
sed before) after depletion. For comparison, an equal amount
f a tryptic digest of cytochrome C was added to the depleted
nd digested sample just prior to LC–MS analysis. Both anal-
ses were repeated nine-times and the average peak areas for
ve selected m/z traces from peptides related to horse heart
ytochrome C were compared. A comparison of peak areas of
ytochrome C added to the original serum or added just prior to
C–MS analysis, revealed that 19–27% of spiked cytochrome C
ere recovered following multiple affinity removal of high abun-
ance proteins (Table 2). Recoveries on the same order were also
ound when 10–63 pmol of cytochrome C were spiked into 20l
erum. The repeatability of the peak areas of spiked cytochrome
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Fig. 2. LC–MS analyses of trypsin-digested serum samples prepared by Method 1 (A) or Method 2 (B). Six repetitions of fraction 2 of the strong cation-exchange
HPLC pre-fractionation step (Method 1) are shown in comparison with five repetitions of Method 2.
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Fig. 3. SDS–PAGE analysis of human serum prior to (lane 5) and after depletion
using the multiple affinity removal column (lanes 1–4) or dye ligand/Protein A
affinity chromatography (lane 6). Albumin is labelled with an asterisk.
Table 2
Recovery of horse heart cytochrome C (Method 2) added to human serum prior
to depletion (210 pmol in 20l serum) of high abundance proteins using the mul-
tiple affinity removal column (Agilent; depletes albumin, IgG, IgA, transferrin,
haptoglobin, and 1-antitrypsin) based on extracted ion chromatograms (results
based on 9 independent experiments with and without addition of cytochrome
C)
m/z Peak area Recovery % RSD % (n = 9)
302.7 1233449 19.1 6.1
604.4 12538882 27.3 8.6
482.8 27618370 26.0 10.8
748.4 39544944 26.4 7.0
1495.7 504101 20.3 7.5
Average recovery 23.8 Average RSD 8.0
C was between 12 and 26% RSD (not shown) and thus within the
same range as relative standard deviations for other endogenous
peptide peaks (see Table 1). Repeatability of the initial depletion
step itself was assessed to be better than 5% RSD in terms of
Fig. 4. Image plots showing the colour-coded CODA quality scores of the dif-
ferent mass traces (m/z 100–1500). High quality values are red (in web version)
and low quality values are blue (in web version). The image plot at the top dis-
plays quality values for the 6 replicates (the second fraction is displayed) using
Method 1 (see Fig. 2A). The image plot at the bottom shows the quality values
of 5 replicates measured using sample preparation Method 2 (see Fig. 2B).
peak area of the flow-through fraction of the multiple affinity
removal column.
To investigate whether loss of cytochrome C was due to direct
binding to the affinity column or mediated through binding to
high abundance proteins, similar amounts of cytochrome C were
dissolved in Buffer A and applied to the multiple affinity removal
column. Practically all cytochrome C was recovered showing
clearly that binding to high abundance proteins, most likely albu-
min, was responsible for the loss. Therefore, the actual amounts
of cytochrome C applied to LC–MS analysis in the compara-
tive spiking studies shown in Fig. 5 were about five times lower
Fig. 5. (A) Principal component analysis (PCA) biplot of trypsin digested, depleted h
serum (red diamonds (in web version)) and without cytochrome C (blue squares (in
threshold of 0.98. Note that the recovery of cytochrome after depletion is only 20–25
triangles (in web version). (B) Enlarged part of the boxed area in (A) showing that pe
spiked and non-spiked. All of these peaks are derived from cytochrome C.uman serum samples with 210 pmol spiked horse heart cytochrome C in 20L
web version)) after selection of high quality mass traces with CODA using a
% (see Table 2). The used high quality mass traces are indicated by the green
aks at m/z 483, 965 and 748 contribute strongly to the discrimination between
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Fig. 6. Principal component analysis (PCA) biplot of human serum samples
spiked with increasing amounts of horse heart cytochrome C (25, 50, 100, 210,
610 and 1260 pmol in 20L original serum, recalculated for an injected amount
corresponding to 10% of the original 20 (l). Peaks (m/z values) used for PCA
(selected by CODA) are shown as red triangles (in web version). Peaks with m/z
483 and 749 contribute strongly to the observed trend in PC1. Both peaks are
derived from cytochrome C.
than the amount originally added to the serum sample. These
results confirmed the observation that high-abundance proteins
may act as “molecular sponges”, which bind and transport low
molecular weight proteins or peptides an effect that needs to be
corrected for when using spiked internal standards.
In an effort to evaluate whether Method 2 in combination
with CODA and PCA could detect a trend in concentration of a
protein in serum, different amounts of horse heart cytochrome C
(25 pmol–1.26 nmol) were added to 20l of the original serum
sample before multiple depletion and 10% of the tryptic digest
was subjected to LC–MS as described above. In Fig. 6 mul-
tivariate statistical data analysis (PCA) results are displayed of
LC–MS datasets treated with CODA to generate peak lists based
on high quality mass traces (CODA score > 0.98). These results
show that principal component 1 (PC1), which describes about
89% of the variability in the data, follows the concentration
trend generated by the added cytochrome C down to a level of
5 pmol in the equivalent of 2L serum (recalculated for an injec-
tion of 10% of the original sample). Variability reflected in PC2
(approximately 7%) is not correlated with the concentration of
cytochrome C. The serum sample containing 2.5 pmol follows
the trend described by PC1 but is separated from the other sam-
ples mainly in PC2 most likely due to variability introduced by
the analytical procedure. PCA analysis showed again that traces
at m/z 483 and 748, corresponding to peptides derived from












A procedure for the depletion of high abundance proteins
from human serum for subsequent analysis by shotgun pro-
teomics using LC–MS has been described. The overall pro-
cedure showed a repeatability of 10–30% for peak area and
better than 0.1% for retention times without the use of inter-
nal standards or alignment of the chromatograms. Data were
pre-processed using CODA at a quality score threshold of 0.98
that selects about 45 of the most “information rich” m/z traces.
This allowed to reconstruct a TIC highly similar to the original
raw data, however, with drastically reduced background noise.
PCA of pre-processed LC–MS datasets obtained after spiking
different amounts of horse heart cytochrome C into the origi-
nal serum (range 25 pmol–1.26 nmol in 20l serum) allowed
to reveal the trend in cytochrome C concentrations in Princi-
pal Component 1, which described 89% of the variability in the
data. Determination of recoveries for spiked cytochrome C after
depletion using a multiple affinity removal column depleting
albumin, IgG, IgA, transferrin, haptoglobin, and 1-antitrypsin
showed that only 20–25% of the added protein were recovered
and that this loss was due to the presence of high abundance
proteins and not to direct binding to the affinity column. The
effect of protein co-depletion needs therefore to be taken into
account when adding internal standards to serum and likely






























srend (see Fig. 6). Method 2 combined with m/z trace selec-
ion by CODA and PCA thus correctly identified 2 m/z values
hat correlated with the observed trend in PC1 and the intro-
uced concentrations of cytochrome C added to the serum. In
rder to evaluate whether there is a good correlation between the
etected m/z traces and the amount of added cytochrome C, a
inear correlation analysis was performed showing that the peak
reas of the extracted ion chromatograms at 483 and 748 amu
orrelated well with the added amounts over the studied con-
entration range (R2 = 0.97–0.99).nternal standardization using added marker peptides is a viable
lternative to stable isotope labeling for quantitative, compara-
ive proteomics but that care needs to be taken to account for
imited recoveries. Operating according to a strictly standard-
zed procedure is mandatory. Other groups have also shown that
eliable quantitative results in shotgun proteomics of complex
eptide mixtures can be obtained based on reproducible peak
reas [29–30]. However, repeatability may still be improved
sing the so-called “Global Internal Standard” strategy based on
table isotope labeled samples [31], an approach that is under
nvestigation.
While our approach shows the feasibility of combining an
C–MS based method including depletion of high-abundance
roteins and trypsin digestion with data pre-processing and mul-
ivariate statistics to discover trends in concentrations of proteins
n complex mixtures like serum, the concentration sensitivity is
ot sufficient to reach into the range of known tumor markers
ng/ml range). Improvements will therefore have to be made in
ample preparation with the goal of being able to treat a larger
olume of serum. Our analysis eventually used only 2l of
he original serum sample, while it is possible to obtain 1ml
ithout difficulty. Due to the high remaining protein content
ven after depletion (approximately 4–5 mg/ml), it is pivotal to
tart with a “preparative” separation method and to analyze the
refractionated sample. We are presently investigating prefrac-
ionation strategies at the protein level prior to tryptic digestion to
each a better concentration sensitivity. The described method
s currently being applied to comparative cross-sectional and
ongitudinal studies with samples from healthy subjects and cer-
ical cancer patients at different stages of disease to evaluate its
uitability to classify different groups of patients.
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